Even worse than ‘Recovery,’ potentially lethal hydroxychloroquine study in patients near death
What could be worse than giving potentially lethal doses of hydroxychloroquine to Hospitalized Covid-19 patients? The REMAP-Covid study is using the same HCQ dose as the Recovery trial for 6 days. But it is even worse for the following reasons: You have to be close to death, either on a …